A novel paclitaxel coated balloon with increased drug transfer for treatment of complex vascular lesions.
<h4>Background</h4>Drug coated balloons (DCB) with paclitaxel (Ptx) dose of 2-3.5 μg/mm2 balloon surface inhibit restenosis with different effectiveness and duration of success. A clinical dose finding study is not known for any of the currently marketed products. The aim of the present...
Guardado en:
Autores principales: | Ole Gemeinhardt, Beatrix Schnorr, Ulrich Speck, Bruno Scheller |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/75e61c76906c4cc6b18d6202167a6932 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A novel paclitaxel coated balloon with increased drug transfer for treatment of complex vascular lesions
por: Ole Gemeinhardt, et al.
Publicado: (2021) -
In vitro determination of drug transfer from drug-coated balloons.
por: Anne Seidlitz, et al.
Publicado: (2013) -
Paclitaxel- and Sirolimus-coated Balloons in Peripheral Artery Disease Treatment: Current Perspectives and Concerns
por: Masayuki Mori, et al.
Publicado: (2021) -
Drug coated balloons for coronary artery bifurcation lesions: A systematic review and focused meta-analysis.
por: Natasha H Corballis, et al.
Publicado: (2021) -
Treatment of cephalic arch stenosis in dysfunctional arteriovenous fistulas with paclitaxel-coated versus conventional balloon angioplasty
por: Ren Kwang A. Tng, et al.
Publicado: (2021)